许多出版物提出了立体定位消融体放射治疗（SABR）的质量标准。然而，有关这些指南遵守程度的数据在文献中缺乏。本研究旨在了解这些指南在临床中的应用情况，并确定实施此类建议的障碍。访问了新南威尔士州放射肿瘤学中心的多学科工作人员，围绕RANZCR立体定位体放射治疗安全实践指南制定了问卷。对采访回答进行了分组，评估了指南，并进行了主题分析。发现指南的符合度良好，超过80%的中心在大部分主题上都取得了满意的结果。符合度最低的领域是审核、风险评估和报告建议。 SABR治疗质量的障碍包括培训机会有限、病人数量少以及对全面审计和报告缺乏明确要求。总的来说，受访中心报道了对大多数RANZCR SABR指南的良好遵守情况。符合度最低的任务是监测质量结果。改进的潜在策略包括纳入临床试验和使用链接治疗参数、剂量计算和结果的数据库。进一步的工作将集中于调查中发现的障碍，并提出解决这些领域的实际解决方案。© 2023 The Authors. Journal of Medical Imaging and Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of the Royal Australian and New Zealand College of Radiologists.

Many publications have proposed quality standards for stereotactic ablative body radiotherapy (SABR). However, data on the level of compliance with these guidelines is lacking in the literature. This study aimed to understand how these guidelines are applied in the clinic and to identify barriers to implementing such recommendations.Interviews were conducted with multidisciplinary staff at radiation oncology centres across New South Wales formulated around the RANZCR Guidelines for Safe Practice of Stereotactic Body (Ablative) Radiation Therapy. The interview responses were grouped into 20 topics, assessed against the guidelines and thematically analysed.Good compliance with the guidelines was found, with more than 80% of centres achieving satisfactory results in more than half the topics. The areas with the lowest compliance were auditing, risk assessment and reporting recommendations. Barriers to the quality of SABR treatments included limited training opportunities, low patient numbers and a lack of clear requirements on comprehensive auditing and reporting.Overall, the centres surveyed reported good compliance with most of the RANZCR SABR guidelines. The tasks with the lowest compliance were those that monitor quality outcomes. Potential strategies for improvement include inclusion in clinical trials and the use of databases which link treatment parameters, dosimetry and outcomes. Further work will focus on the barriers identified in this survey and propose practical solutions to improve compliance in these areas.© 2023 The Authors. Journal of Medical Imaging and Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Radiologists.